Document is current
Any future updates will be listed below
-
Authors
Al Nakouzi, Nader
Wang, Chris Kedong
Beraldi, Eliana
Jager, Wolfgang
Ettinger, Susan
Fazli, Ladan
Nappi, Lucia
Bishop, Jennifer
Zhang, Fan
Chauchereau, Anne
Loriot, Yohann
Gleave, Martin https://orcid.org/0000-0003-4235-0167
-
Funding
Funding for this research was provided by:
Terry Fox New Frontiers Program (TFF116129)
Prostate Cancer Foundation of British Columbia (PCFBC postdoctoral grant 2013)
Prostate Cancer Canada (T2013‐01)
- License Information
-
More Information
Article History
Received: 13 November 2015
Revised: 14 April 2016
Accepted: 18 April 2016
First Online: 19 May 2016
Conflict of interest
: By way of disclosure of conflict of interest, the University of British Columbia has submitted patent applications on OGX‐011, listing Dr. Gleave as inventor. This IP has been licensed to OncoGenex Technologies, a Vancouver‐based biotechnology company that Dr. Gleave has founding shares in.
